ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,185Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 1454

$1.46M Total Retail Price of All Prescriptions

Rank: 25 out of 1454

764 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 764 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 764 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 22,490 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 987 840 1 1
LEVOTHYROXINE SODIUM 985 873 2 5
OMEPRAZOLE 861 708 3 3
AMLODIPINE BESYLATE 843 711 4 2
LISINOPRIL 777 594 5 4
FUROSEMIDE 649 588 6 6
HYDROCODONE-ACETAMINOPHEN 583 428 S3 7 7
METOPROLOL TARTRATE 514 443 8 10
METFORMIN HCL 466 353 9 8
NAMENDA 455 450 10 48
WARFARIN SODIUM 449 413 11 17
GABAPENTIN 448 356 12 16
TRAMADOL HCL 426 370 13 20
ALENDRONATE SODIUM 409 383 14 35
MELOXICAM 397 317 15 37
CITALOPRAM HBR 376 333 16 21
POTASSIUM CHLORIDE 371 344 17 15
ATORVASTATIN CALCIUM 367 307 18 11
HYDROCHLOROTHIAZIDE 327 252 19 9
PRAVASTATIN SODIUM 319 255 20 12
SERTRALINE HCL 296 246 21 26
GLIMEPIRIDE 293 238 22 33
ZOLPIDEM TARTRATE 292 231 23 19
NEXIUM 285 200 24 23
CARVEDILOL 266 236 25 24
DONEPEZIL HCL 262 262 26 29
LACTULOSE 257 188 27 152
METOPROLOL SUCCINATE 252 202 28 13
CLOPIDOGREL 250 239 29 32
ISOSORBIDE MONONITRATE ER 229 210 30 46
CLONIDINE HCL 224 161 31 49
TRAZODONE HCL 205 148 32 50
CRESTOR 199 185 33 22
RANITIDINE HCL 199 183 33 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 192 147 35 27
KETOCONAZOLE 190 166 36 260
PLAVIX 189 181 37 45
SYNTHROID 186 171 38 25
ATENOLOL 185 185 39 18
DIOVAN 168 168 40 40
LANTUS 168 141 40 51
TAMSULOSIN HCL 163 137 42 34
PANTOPRAZOLE SODIUM 151 114 43 31
LANTUS SOLOSTAR 149 122 44 79
EXELON 148 148 45 135
FAMOTIDINE 148 124 45 88
OXYCODONE-ACETAMINOPHEN 143 114 S2 47 60
MIRTAZAPINE 143 123 47 53
GLIPIZIDE 137 93 49 62
FENOFIBRATE 131 106 50 68
ALLOPURINOL 131 121 50 28
CARBIDOPA-LEVODOPA 130 118 52 130
POLYETHYLENE GLYCOL 3350 127 112 53 61
DILTIAZEM 24HR CD 122 122 54 76
CYMBALTA 118 97 55 55
METOCLOPRAMIDE HCL 110 89 56 121
AZITHROMYCIN 109 83 57 42
PAROXETINE HCL 105 78 58 73
LOSARTAN POTASSIUM 104 88 59 14
ESCITALOPRAM OXALATE 103 74 60 78
DILTIAZEM 24HR ER 100 100 61 120
KLOR-CON M20 98 94 62 54
PROMETHAZINE HCL 97 81 R 63 82
DIGOXIN 95 95 64 70
GLYBURIDE 95 80 R 64 98
FENTANYL 95 83 S2 64 104
FLUTICASONE PROPIONATE 94 63 67 30
SPIRONOLACTONE 91 67 68 63
SPIRIVA 90 70 69 52
VERAPAMIL ER 89 89 70 89
ADVAIR DISKUS 89 43 70 47
DOXAZOSIN MESYLATE 87 87 72 87
QUETIAPINE FUMARATE 87 67 72 91
OXYBUTYNIN CHLORIDE 86 66 74 169
PROAIR HFA 85 21 75 56
DIOVAN HCT 85 77 75 75
LOVASTATIN 83 79 77 39
CELEBREX 81 59 78 81
LIPITOR 80 68 79 74
RISPERIDONE 79 41 80 86
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 62 81 108
CYCLOBENZAPRINE HCL 77 48 R 82 59
ENDOCET 77 35 S2 82 137
SOTALOL 75 72 84 253
PREDNISONE 75 75 84 36
BENAZEPRIL HCL 73 73 86 57
LEVOXYL 73 73 86 84
NOVOLIN R 73 66 86 180
OXYBUTYNIN CHLORIDE ER 72 61 89 156
DICYCLOMINE HCL 71 24 90 258
NITROFURANTOIN MONO-MACRO 69 63 91 217
INSULIN SYRINGE 68 36 92 97
LEXAPRO 66 43 93 205
ZETIA 66 64 93 69
TOPIRAMATE 65 20 95 192
IPRATROPIUM-ALBUTEROL 64 63 96 151
LEVETIRACETAM 63 38 97 114
LOSARTAN-HYDROCHLOROTHIAZIDE 63 54 97 38
DOXYCYCLINE HYCLATE 62 53 99 110
RESTASIS 61 42 100 267
LYRICA 60 42 101 103
LEVOFLOXACIN 60 54 101 95
VENLAFAXINE HCL ER 59 40 103 105
VYTORIN 58 47 104 170
QUINAPRIL HCL 58 53 104 101
LAMOTRIGINE 57 0 106 187
FORTICAL 56 48 107 336
ROPINIROLE HCL 56 53 107 96
FLUOXETINE HCL 56 49 107 72
NYSTATIN 56 45 107 184
SINGULAIR 55 52 111 83
ENALAPRIL MALEATE 55 55 111 58
RAMIPRIL 54 41 113 66
OXYCODONE HCL-ACETAMINOPHEN 53 24 S2 114 93
PREMARIN 52 23 R 115 131
GLIPIZIDE ER 52 24 115 92
JANUVIA 52 35 115 77
OXYCODONE HCL 51 39 S2 118 80
LIDODERM 50 47 119 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.